Literature DB >> 9052379

The use of amplified variable number of tandem repeats (VNTR) in the detection of chimerism following bone marrow transplantation. A comparison with restriction fragment length polymorphism (RFLP) by Southern blotting.

J J Sreenan1, J D Pettay, A Tbakhi, G Totos, L M Sandhaus, M L Miller, B Bolwell, R R Tubbs.   

Abstract

Chimerism analysis after allogeneic bone marrow transplantation (alloBMT) allows detection of early marrow engraftment, disease relapse, and graft rejection. Our objective was to do retrospective and prospective studies of chimerism analysis by restriction fragment length polymorphism (RFLP) by Southern blotting and variable number of tandem repeats (VNTR) by polymerase chain reaction (PCR) to compare and contrast the methods. The retrospective group comprised 46 samples from 26 patients previously analyzed by RFLP, while the prospective group contained 34 samples from 25 patients. Using four different VNTR primers (D1S80, D17S30, D1S111, and APO-B), the recipient and donor samples amplified by the PCR were screened for unique banding patterns. The VNTR primer with the unique banding pattern was used to detect chimerism in each sample. A total of 635 VNTR analyses were performed. Interpretation was blinded for previous RFLP results. A comparison between the VNTR and RFLP results and a cost analysis of the two procedures were done. A unique VNTR banding pattern was present in 49 of 51 patients (identical twins in one case). The VNTR analysis showed complete chimerism in 68 samples, mixed chimerism in 9, and recurrences in 2. This agreed with the RFLP results in 64 (80%) of 80 samples. Failure to detect 1% to 10% of recipient DNA accounted for 15 (VNTR, 8; RFLP, 7) discordances. Follow-up revealed all donor DNA in five cases, decreasing quantities of recipient DNA in two cases (six samples), and no additional studies available in four cases. In one case, VNTR detected a complete chimerism when the DNA was insufficient for RFLP analysis. The cost analysis revealed an approximately 50% savings with the use of VNTR; VNTR is a viable alternative to RFLP in the detection of chimerism after bone marrow transplantation and offers substantial cost savings, faster turnaround time, easier preparation of the DNA, smaller DNA requirements, and the elimination of radioisotopes and cumbersome restriction enzymes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9052379     DOI: 10.1093/ajcp/107.3.292

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  A novel mutation found in an adrenoleukodystrophy patient who underwent bone marrow transplantation.

Authors:  H Osaka; H Sekiguchi; K Inoue; K Ikuta; Y Sakakihara; A Oka; H Onishi; T Miyakawa; K Suzuki; S Kimura; K Kosaka; S Matsuyama
Journal:  J Inherit Metab Dis       Date:  1998-04       Impact factor: 4.982

2.  Use of single nucleotide polymorphisms (SNP) and real-time polymerase chain reaction for bone marrow engraftment analysis.

Authors:  D H Oliver; R E Thompson; C A Griffin; J R Eshleman
Journal:  J Mol Diagn       Date:  2000-11       Impact factor: 5.568

3.  Canine haematopoietic chimerism analyses by semiquantitative fluorescence detection of variable number of tandem repeat polymorphism.

Authors:  I Hilgendorf; V Weirich; L Zeng; E Koppitz; R Wegener; C Junghanss
Journal:  Vet Res Commun       Date:  2005-02       Impact factor: 2.459

Review 4.  A practical guide to chimerism analysis: Review of the literature and testing practices worldwide.

Authors:  Amanda G Blouin; Fei Ye; Jenifer Williams; Medhat Askar
Journal:  Hum Immunol       Date:  2021-08-14       Impact factor: 2.211

5.  Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases.

Authors:  R A Brodsky; L Luznik; J Bolaños-Meade; M S Leffell; R J Jones; E J Fuchs
Journal:  Bone Marrow Transplant       Date:  2008-07-14       Impact factor: 5.483

6.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

Authors:  Leo Luznik; Paul V O'Donnell; Heather J Symons; Allen R Chen; M Susan Leffell; Marianna Zahurak; Ted A Gooley; Steve Piantadosi; Michele Kaup; Richard F Ambinder; Carol Ann Huff; William Matsui; Javier Bolaños-Meade; Ivan Borrello; Jonathan D Powell; Elizabeth Harrington; Sandy Warnock; Mary Flowers; Robert A Brodsky; Brenda M Sandmaier; Rainer F Storb; Richard J Jones; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2008-06       Impact factor: 5.742

7.  A Census of Tandemly Repeated Polymorphic Loci in Genic Regions Through the Comparative Integration of Human Genome Assemblies.

Authors:  Loredana M Genovese; Filippo Geraci; Lucia Corrado; Eleonora Mangano; Romina D'Aurizio; Roberta Bordoni; Marco Severgnini; Giovanni Manzini; Gianluca De Bellis; Sandra D'Alfonso; Marco Pellegrini
Journal:  Front Genet       Date:  2018-05-02       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.